Literature DB >> 25197924

Response.

Joshua L Kennedy1, Larry Borish, Jared Christophel, Spencer C Payne.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25197924      PMCID： PMC5517775          DOI： 10.2500/ajra.2014.28.0715

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN： 1945-8932            Impact factor:   2.467


× No keyword cloud information.
  12 in total

Review 1.  Subcutaneous and sublingual immunotherapy for allergic rhinitis: what is the evidence?

Authors:  Sarah K Wise; Rodney J Schlosser
Journal:  Am J Rhinol Allergy       Date:  2012 Jan-Feb       Impact factor: 2.467

2.  Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract.

Authors:  Sheila M Amar; Ronald J Harbeck; Michael Sills; Lori J Silveira; Holly O'Brien; Harold S Nelson
Journal:  J Allergy Clin Immunol       Date:  2009-06-11       Impact factor: 10.793

3.  Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma.

Authors:  P Berto; M Bassi; C Incorvaia; F Frati; P Puccinelli; C Giaquinto; L Cantarutti; C Ortolani
Journal:  Eur Ann Allergy Clin Immunol       Date:  2005-10

4.  Effects of sublingual immunotherapy for multiple or single allergens in polysensitized patients.

Authors:  Maurizio Marogna; Igino Spadolini; Alessandro Massolo; Pietro Zanon; Daniele Berra; Elena Chiodini; Walter G Canonica; Giovanni Passalacqua
Journal:  Ann Allergy Asthma Immunol       Date:  2007-03       Impact factor: 6.347

5.  Clinical and immunologic effects of sublingual immunotherapy on patients with allergic rhinitis to house-dust mites: 1-year follow-up results.

Authors:  Seung-Tae Kim; Doo Hee Han; Il Joon Moon; Chul Hee Lee; Yang-Gi Min; Chae-Seo Rhee
Journal:  Am J Rhinol Allergy       Date:  2010 Jul-Aug       Impact factor: 2.467

6.  Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma--a placebo controlled study.

Authors:  D Mungan; Z Misirligil; L Gürbüz
Journal:  Ann Allergy Asthma Immunol       Date:  1999-05       Impact factor: 6.347

7.  Economic evaluation of sublingual immunotherapy vs symptomatic treatment in adults with pollen-induced respiratory allergy: the Sublingual Immunotherapy Pollen Allergy Italy (SPAI) study.

Authors:  Patrizia Berto; Giovanni Passalacqua; Nunzio Crimi; Franco Frati; Claudio Ortolani; Gianenrico Senna; Giorgio Walter Canonica
Journal:  Ann Allergy Asthma Immunol       Date:  2006-11       Impact factor: 6.347

Review 8.  Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.

Authors:  Sandra Y Lin; Nkiruka Erekosima; Julia M Kim; Murugappan Ramanathan; Catalina Suarez-Cuervo; Yohalakshmi Chelladurai; Darcy Ward; Jodi B Segal
Journal:  JAMA       Date:  2013-03-27       Impact factor: 56.272

9.  Economic evaluation of sublingual immunotherapy vs. symptomatic treatment in allergic asthma.

Authors:  Renato Ariano; Patrizia Berto; Cristoforo Incorvaia; Giuseppe Di Cara; Rachele Boccardo; Stefania La Grutta; Paola Puccinelli; Franco Frati
Journal:  Ann Allergy Asthma Immunol       Date:  2009-09       Impact factor: 6.347

10.  Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.

Authors:  Alain Didier; Hans-Jörgen Malling; Margitta Worm; Friedrich Horak; Siegfried Jäger; Armelle Montagut; Claude André; Olivier de Beaumont; Michel Melac
Journal:  J Allergy Clin Immunol       Date:  2007-11-01       Impact factor: 10.793
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.